Showing results (491-500 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|April 25, 2022
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trialAmalia Gastaldelli, Kenneth Cusi, Laura Fernández Landó, et al.
The Lancet. Diabetes & Endocrinology|October 17, 2021
Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis
The Lancet. Diabetes & Endocrinology|February 20, 2022
A global view of the interplay between non-alcoholic fatty liver disease and diabetesNorbert Stefan, Kenneth Cusi
The Lancet. Diabetes & Endocrinology|February 3, 2022
Sexual dimorphism in COVID-19: potential clinical and public health implicationsNicole Bechmann, Andreas Barthel, Andreas Schedl, et al.
The Lancet. Diabetes & Endocrinology|March 10, 2022
The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020Margherita Pizzato, Mengmeng Li, Jerome Vignat, et al.
The Lancet. Diabetes & Endocrinology|March 3, 2022
The relevance of T3 in the management of hypothyroidismDomenico Salvatore, Tommaso Porcelli, Matthew D Ettleson, et al.
The Lancet. Diabetes & Endocrinology|July 1, 2019
The role of blood volume in cardiac dysfunction and reduced exercise tolerance in patients with diabetesDavid Montero, Candela Diaz-Canestro, Laura Oberholzer, et al.
The Lancet. Diabetes & Endocrinology|January 9, 2023
Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trialKausik K Ray, Roel P T Troquay, Frank L J Visseren, et al.
The Lancet. Diabetes & Endocrinology|May 1, 2021
Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort studyMin Gao, Carmen Piernas, Nerys M Astbury, et al.
The Lancet. Diabetes & Endocrinology|May 2, 2021
A community-based, multi-level, multi-setting, multi-component intervention to reduce weight gain among low socioeconomic status Latinx children with overweight or obesity: The Stanford GOALS randomised controlled trialThomas N Robinson, Donna Matheson, Darrell M Wilson, et al.
Pageof 93